Evaluation of the anti-ageing efficacy of Hilow Haenkenium cream in healthy wome
- Conditions
- Mild-to-moderate ageing skin signs and skin redness due to cold and windNot Applicable
- Registration Number
- ISRCTN12067877
- Lead Sponsor
- IBSA Farmaceutici Italia S.r.l.
- Brief Summary
2020 Results article in https://ita.calameo.com/read/004333467600e607e3bcd Pages 25-33 (added 20/08/2021)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Female
- Target Recruitment
- 50
1. Healthy female subject
2. Caucasian ethnicity
3. Age between 40 and 65 years old
4. Subjects showing mild to moderate ageing skin signs and skin redness due to cold and wind
5. Subjects who have not been recently involved in any other similar study
6. Willingness to use during all the study period only the product to be tested
7. Willingness to not vary the normal daily routine
1. Subject does not meet the inclusion criteria
2. Positive history for atopy or hypersensitive skin
3. Past history of allergy or sensitivity to cosmetics, toiletries, to solar and/or topical medications
4. Any skin condition that the principal investigator deems inappropriate for participation
5. Pregnancy or nursing women
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Antiageing efficacy is measured by means of wrinkle depth and total skin antioxidant capacity using Ferric Reducing Antioxidant Power (FRAP) assay at baseline, and after 14, 28, 56 and 84 days of product use.
- Secondary Outcome Measures
Name Time Method Skin redness and skin elasticity/compactness assessed using clinical assessment carried out by the dermatologist and the self-assessment carried out by the subjects participating in the study at baseline, and after 14, 28, 56 and 84 days of product use.